Impact of the novel influenza A (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile

Clinical Infectious Diseases

Volumn 50, Issue 6, 2010, Pages 860-868

  Torres, Juan Pablo ^a,d   O'Ryan, Miguel ^d   Herve, Beatrice ^b   Espinoza, Ricardo ^c   Acuña, Guillermo ^c   Mañalich, Jaime ^a   Chomalí, May ^a  

^a CLÍNICA LAS CONDES   (Chile)

^b Department of Microbiology ^*  (Chile)

^c Department of Internal Medicine   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; INFLUENZA VACCINE; OSELTAMIVIR; VIRUS HEMAGGLUTININ; ZANAMIVIR;

ADENOVIRUS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARTICLE; ASSISTED VENTILATION; BRONCHUS OBSTRUCTION; CARDIOGENIC SHOCK; CHILD; CHILE; CLINICAL FEATURE; COMORBIDITY; EMERGENCY WARD; EPIDEMIC; EPILEPTIC STATE; FEBRILE CONVULSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PNEUMONIA; PNEUMOTHORAX; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SEX DIFFERENCE; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS GENE;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CHILE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NASOPHARYNX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77749277122     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/650750     Document Type: Article

References (20)

1. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459(7249):931-939.
2. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360(25): 2605-2615.
3. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses-New Zealand, 2009. MMWR Morb Mortal Wkly Rep 2009;58(33):918-921.
4. Depoortere E, Mantero J, Lenglet A, Kreidl P, Coulombier D. Influenza A(H1N1)v in the southern hemisphere-lessons to learn for Europe? Euro Surveill 2009;14(24):l-2.
5. Lagos R, Avendafio LF, Levine MM. Systematic surveillance of influenza, syncytial respiratory, parainfluenza and adenovirus in children with acute respiratory infections [in Spanish], Rev Med Chil 1999; 127(9):1063-1072.
6. Ministerio de Salud. Reporte diario de situación de influenza AH1N1. 31 May 2009. http://www.redsalud.gov.cl/portal/url/item/ 6b64ba57cbfea979e04001011f01072f.pdf. Accessed 30 September 2009.
7. Gobierno de Chile. Ministerio de Salud. Division de Prevención y Control de Enfermedades. Guía clínica para el manejo de casos nueva influenza humana A (H1N1) (IHA H1N1) etapa de mitigación. 9 June 2009. http://www.redsalud.gov.cl/portal/url/item/ 6bl4a541236acdeae04001011f010eda.pdf. Accessed 30 September 2009.
8. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009;49(7):1090-1093.
9. Panning M, Eickmann M, Landt O, et al. Detection of influenza A(HlNl)V virus by real-time RT-PCR. Euro Surveill 2009;14(36):l-6.
10. Mcintosh K, Hendry RM, Fahnestock ML, Pierik LT. Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol 1982;16(2): 329-333. (Pubitemid 12049095)
11. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374(9688): 451-458.
12. Relio J, Rodriguez A, Ibanez P, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 2009;13(5):R148.
13. Webb SA, Seppelt IM; ANZIC Influenza Investigators. Pandemic (H1N1) 2009 influenza ("swine flu") in Australian and New Zealand intensive care. Crit Care Resusc 2009;11(3):170-172.
14. Gilsdorf A, Poggensee G; Working Group Pandemic Influenza A(H1N1)v. Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 2009;14(34):1-4.
15. Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill. 2009;14(34):l-6.
16. Lister P, Reynolds F, Parslow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009;374(9690):605-607.
17. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009-update. Wkly Epidemiol Rec 2009;84(30):305-308.
18. Influenza pandémica (H1N1). Ministerio de Salud de Chile. Reporte 3 November 2009. http://www.pandemia.cl/pagnew/prensa/REPORTE-04-1 l-09.pdf. Accessed 30 September 2009.
19. Piedra PA, Schulman KL, Blumentals WA. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics 2009;124(1):170-1.78.
20. Influenza pandémica (H1N1). Ministerio de Salud de Chile. Reporte 9 September 2009. http://www.pandemia.cl/pagnew/prensa/REPORTE-09-09-09.pdf. Accessed 30 September 2009.